Stark H - Search Results

1

Histamine H₃ receptor antagonists/inverse agonists: Where do they go?

Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Ghamari N, et al. Among authors: stark h. Pharmacol Ther. 2019 Aug;200:69-84. doi: 10.1016/j.pharmthera.2019.04.007. Epub 2019 Apr 24. Pharmacol Ther. 2019. PMID: 31028835 Review.

2

Design of histamine H3-receptor agonists and antagonists.

Schunack W, Stark H. Schunack W, et al. Among authors: stark h. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):173-8. doi: 10.1007/BF03188918. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867658 Review.

3

Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Schlicker E, Kathmann M, Reidemeister S, Stark H, Schunack W. Schlicker E, et al. Among authors: stark h. Br J Pharmacol. 1994 Aug;112(4):1043-8. doi: 10.1111/j.1476-5381.1994.tb13188.x. Br J Pharmacol. 1994. PMID: 7952862 Free PMC article.

4

[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.

Ligneau X, Garbarg M, Vizuete ML, Diaz J, Purand K, Stark H, Schunack W, Schwartz JC. Ligneau X, et al. Among authors: stark h. J Pharmacol Exp Ther. 1994 Oct;271(1):452-9. J Pharmacol Exp Ther. 1994. PMID: 7965746

5

Development of a binding site model for histamine H3-receptor agonists.

Sippl W, Stark H, Höltje HD. Sippl W, et al. Among authors: stark h. Pharmazie. 1998 Jul;53(7):433-7. Pharmazie. 1998. PMID: 9699219

6

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J. Ligneau X, et al. Among authors: stark h. J Pharmacol Exp Ther. 1998 Nov;287(2):658-66. J Pharmacol Exp Ther. 1998. PMID: 9808693

7

General construction pattern of histamine H3-receptor antagonists: change of a paradigm.

Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2011-6. doi: 10.1016/s0960-894x(98)00342-4. Bioorg Med Chem Lett. 1998. PMID: 9873477

8

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.

Stark H, Ligneau X, Sadek B, Ganellin CR, Arrang JM, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 2000 Oct 16;10(20):2379-82. doi: 10.1016/s0960-894x(00)00473-x. Bioorg Med Chem Lett. 2000. PMID: 11055360

9

Different antagonist binding properties of human and rat histamine H3 receptors.

Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 2001 Apr 9;11(7):951-4. doi: 10.1016/s0960-894x(01)00090-7. Bioorg Med Chem Lett. 2001. PMID: 11294398

10

Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.

Nickel T, Bauer U, Schlicker E, Kathmann M, Göthert M, Sasse A, Stark H, Schunack W. Nickel T, et al. Among authors: stark h. Br J Pharmacol. 2001 Apr;132(8):1665-72. doi: 10.1038/sj.bjp.0704013. Br J Pharmacol. 2001. PMID: 11309237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,194 results

Search Page

Filters